Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome.
about
Granulocyte transfusions in the G-CSF era. Where do we stand?Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation.The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients.Management of bacteremia in patients undergoing hematopoietic stem cell transplantation.Increased Level of IFN-γ and IL-4 Spot-Forming Cells on ELISPOT Assay as Biomarkers for Acute Graft-Versus-Host Disease and Concurrent Infections.Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis.Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients.Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies.Stenotrophomonas maltophilia bacteraemia in 40 haematology patients: risk factors, therapy and outcome.Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients.
P2860
Q35845544-F9546159-0A70-49CA-B210-4D439FCEB856Q36445952-67C87FD2-0781-47D8-87EA-24EC160383A3Q37417446-E93D41B3-E2D8-41AB-9C7C-912111D49243Q37503363-FDC1E279-13B3-4B3C-822D-4364EF60FC75Q37512197-63CABFBD-003C-4772-8CD1-FD7A20C4A670Q39202357-2BA5CCBD-CD34-4997-9B34-C7DF4D8933AFQ41549771-23EC66C3-29D7-45FB-96A4-D01D9075D8DBQ42222497-2164005E-2668-4634-A48F-575A79D810B7Q44457212-C9C051FC-6376-4542-A9CD-6E91BA6C9F0EQ47588284-24E3ACFA-F931-46ED-8442-A3B1C75AB949Q48956027-FF6D9FC5-4B68-4D13-BAD9-80CD936E6D26
P2860
Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Gram-negative bacteraemia (GNB ...... phylaxis, therapy and outcome.
@en
type
label
Gram-negative bacteraemia (GNB ...... phylaxis, therapy and outcome.
@en
prefLabel
Gram-negative bacteraemia (GNB ...... phylaxis, therapy and outcome.
@en
P2093
P2860
P356
P1476
Gram-negative bacteraemia (GNB ...... phylaxis, therapy and outcome.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704338
P407
P577
2004-02-01T00:00:00Z
P5875
P6179
1029556235